BTE25ANTIGENN
Immunochromatographic test designed for the qualitative detection of SARS-CoV-2 specific antigen in a human nasopharyngeal swab specimen. It is intended to be used by professionals as a screening test and as an aid in the early diagnosis of SARS-CoV-2 infection.
SARS-CoV-2 infection.
- French design and manufacture
- Rapid and reliable detection of SARS-CoV-2 antigens:
Results in 15 minutes
Sensitivity: 98.8%; Specificity: 100.0
Detects N protein and new variants of COVID-19 virus.
- Convenient to use:
No additional equipment required, can be performed in the clinic.
Can also be used to support public health strategies, such as contact tracing and large-scale testing of people suspected of having an active infection.
- Sold in boxes of 25 units
- Contents of one box :
25 swabs
25 COVID-19 rapid test cassettes packaged in an individual foil pouch
1 bottle of extraction buffer
25 extraction tubes and dropper caps
Instructions for use
Listed by the French Ministry of Health.
Advantages of the product:
- French design and manufacture
- Fast and reliable detection
- Practice to use
- Eligible for reimbursement and listed by the Ministry of Health
| Characteristic | Value |
|---|---|
| Packaging | Box of 25 kits |
In-vitro diagnostic medical device.
In vitro diagnostic medical devices. Classification: Other tests. Read carefully the instructions in the leaflet accompanying the medical device. According to the notice n° 2021.0015/AC/SEAP of 15 March 2021, the test is intended for in vitro diagnostic use for professional use. Documentation intended for the health professional. Photographs are not contractual.